Acellular Pertussis Completed Phase Trials for Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)

DBCOND0031302 (Acellular Pertussis)CompletedNot Available IdentifierTitlePurposeDrugs
NCT00908115Post Market Surveillance for Infanrix™
NCT01929291Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea
NCT00146835Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine
NCT00297856Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine
NCT02447978Duration of Protection: GSK DTaP Vaccines